MPO and kidney disorder: Myeloperoxidase function have been implicated in endothelial dysfunction and vascular damage in the context of cardiovascular (Baldus et al., 2004; Vita et al., 2004; Teng et al., 2017) and kidney diseases (Lehners et al., 2014; Kisic et al., 2016; Zeng et al., 2018).